Company Filing History:
Years Active: 2006
Title: Paul Richard Blelock Samuel: Innovator in Digital Medical Image Analysis
Introduction
Paul Richard Blelock Samuel is a notable inventor based in London, GB. He has made significant contributions to the field of medical technology, particularly in the area of digital medical image analysis. His innovative approach utilizes algorithms to enhance the analysis of medical images, providing valuable insights for healthcare professionals.
Latest Patents
Samuel holds a patent for a groundbreaking method in digital medical image analysis. This patent involves analyzing a medical image using an algorithm that requires specific input parameters. The values for these parameters are derived from metadata, which indicates various properties of the medical image. For instance, the metadata may reveal the type of image acquisition device or the settings used during the image creation process. Additionally, it may relate to the patient on whom the image is based. This innovative method allows for the selection of optimum values for the parameters, thereby improving the accuracy and effectiveness of medical image analysis. He has 1 patent to his name.
Career Highlights
Samuel is currently employed at Medicsight Plc, a company dedicated to advancing medical imaging technology. His work at Medicsight has positioned him as a key player in the development of innovative solutions that enhance the diagnostic capabilities of medical professionals.
Collaborations
Throughout his career, Samuel has collaborated with esteemed colleagues, including Jamshid Dehmeshki and Susan Alyson Wood. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and the development of cutting-edge technologies in the medical field.
Conclusion
Paul Richard Blelock Samuel is a distinguished inventor whose work in digital medical image analysis has the potential to transform the healthcare industry. His innovative methods and collaborations with other professionals highlight his commitment to advancing medical technology.